[Update Giant Cell Arteriitis]
Claudia Dechant1, Hendrik Schulze-Koops1
1Sektion Rheumatologie und Klinische Immunologie, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München.
Abstract:
Giant cell arteriitis (GCA) is the most common systemic vasculitis in patients ≥ 50 years. GCA belongs to the group of large vessel vasculitides. Clinical hallmarks of GCA are persistent localized headache, jaw claudication, limb claudication, symptoms of polymyalgia rheumatica, constitutional symptoms and acute visual symptoms. A fast track diagnostic workup and subsequent immediate treatment are crucial to avoid persistent ischemic lesions, particularly blindness. This article reviews the EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice and the 2018 update of the EULAR recommendations for the management of large vessel vasculitis with a focus on GCA and new data on the value of tocilizimab in the treatment of GCA.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease I: Introduction
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Glaucoma: Overview


